Member access

4-Traders Homepage  >  Shares  >  Italian Stock Exchange  >  DiaSorin SpA    DIA   IT0003492391

DIASORIN SPA (DIA)

12
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Italian Stock Exchange
01/19/2015 01/20/2015 01/21/2015 01/22/2015 01/23/2015 Date
33.77(c) 33.87(c) 34.3(c) 34.59(c) 35.1(c) Last
69 470 42 694 56 585 64 343 117 173 Volume
-0.35% +0.30% +1.27% +0.85% +1.47% Change
More quotes
Company
DiaSorin SpA engages in the development, production, and marketing reagent kits for in vitro diagnostics.It operates through the Immunodiagnostics and Molecular Diagnostics segments.The Immunodiagnostics segment manufactures and distributes immunoreagent kits based on chemiluminescence,... 
More about the company
Surperformance© ratings of DiaSorin SpA
Trading Rating : Investor Rating :
More Ratings
Chart DIASORIN SPA
Duration : Period :
DiaSorin SpA Technical Analysis Chart | DIA | IT0003492391 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 443 M
EBIT 2014 134 M
Net income 2014 83,9 M
Finance 2014 76,5 M
Yield 2014 1,44%
Sales 2015 473 M
EBIT 2015 147 M
Net income 2015 92,4 M
Finance 2015 109 M
Yield 2015 1,57%
PER 2014 22,99
PER 2015 20,60
EV / Sales 2014 4,26x
EV / Sales 2015 3,92x
Capitalization 1 964 M
More Financials
Latest news on DIASORIN SPA
01/13 DIASORIN : Sources Sought Notice - 66-- 501-15-3-085-0038 Diasorin Analyzer, Rea..
2014DIASORIN SPA : quaterly earnings release
2014 DIASORIN : launches the stool test for Adenovirus on LIAISON
2014 DIASORIN : Announces New Webinar in Their Annual Vitamin D Series
2014 DIASORIN : The Board of Directors approves the results for H1'14
2014 DIASORIN : Confirms its eligibility for the pea-pme
2014 DIASORIN : launches the test for Vitamin D 1,25 on LIAISON
2014 DIASORIN SPA : ex-dividend day for annual dividend
More news
Sector news Diagnostic & Testing Substances
01/24 ESSILOR INTL : among world’s most sustainable companies for third year run..
01/23 IDEXX LABORATORIES : to Release 2014 Fourth Quarter and Full-Year Financial Resu..
01/23 COVIDIEN : Supports Retreat and Refresh Stroke Camp for Stroke Survivors and Car..
Plus d'actualités du secteur Diagnostic & Testing Substances


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF